Clinical trial
Parental Decision-Making for Children With Relapsed Neuroblastoma
NCT02282735 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Parental Decision-Making for Children With Relapsed Neuroblastoma
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 31, 2013
- Completion date
- June 30, 2027
- Enrollment
- 96 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
relapsed neuroblastoma